Product Information
VEMLIDY 25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $51.9830 per EA under NDC 61958230101. Its NADAC has been published 484 times since May 17, 2017.
FDA first approved this application on Nov 10, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958230101
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA208464FDA Approved
11/10/2016
TE Code
AB
On Market Since
11/10/2016
Pharmacological Classes
Price Statistics
The NADAC for VEMLIDY 25 MG TABLET has been published 484 times since May 17, 2017, and over the history we have for it it has risen 63.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $51.9830 per EA |
|---|---|
| All-time high | $51.9830 (Aug 19, 2026) |
| All-time low | $31.8880 (May 17, 2017) |
| 52-week high | $51.9830 |
| 52-week low | $49.0144 |
| Median price | $39.5640 |
| Average price | $41.1602 |
| Largest weekly change | +6.9% (Jan 10, 2018) |
| Weeks tracked | 484 |
| Tracking since | May 17, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tenofovir alafenamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VEMLIDY 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VEMLIDY 25 MG TABLET, manufactured by Gilead Sciences, Inc., is $51.9830 per EA (NDC 61958230101), effective Aug 19, 2026.
How has the price of VEMLIDY 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for VEMLIDY 25 MG TABLET has risen 63.0%. It has been tracked across 484 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for VEMLIDY 25 MG TABLET?
Since May 17, 2017, the NADAC for VEMLIDY 25 MG TABLET has ranged from a low of $31.8880 (May 17, 2017) to a high of $51.9830 (Aug 19, 2026), with a median of $39.5640 per EA.
Are there cheaper alternatives to VEMLIDY 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VEMLIDY 25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VEMLIDY 25 MG TABLET?
VEMLIDY 25 MG TABLET (NDC 61958230101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.